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Comprehensive identification of cis-regulatory elements is neces-
sary for accurately reconstructing gene regulatory networks. We
studied proximal promoters of human and mouse genes with
differential expression across 56 terminally differentiated tissues.
Using in silico techniques to discover, evaluate, and model inter-
actions among sequence elements, we systematically identified
regulatory modules that distinguish elevated from inhibited ex-
pression in the corresponding transcripts. We used these putative
regulatory modules to construct a single predictive model for each
of the 56 tissues. These predictors distinguish tissue-specific ele-
vated from inhibited expression with statistical significance in 80%
of the tissues (45 of 56). The predictors also reveal synergy
between cis-regulatory modules and explain large-scale tissue-
specific differential expression. For testis and liver, the predictors
include computationally predicted motifs. For most other tissues,
the predictors reveal synergy between experimentally verified
motifs and indicate genes that are regulated by similar tissue-
specific machinery. The identification in proximal promoters of
cis-regulatory modules with tissue-specific activity lays the
groundwork for complete characterization and deciphering of
cis-regulatory DNA code in mammalian genomes.
cis-regulatory modules  transcription factor binding
A major first step toward comprehensively understanding thedifferential control of gene expression in specific tissues and
developmental stages is mapping the functional cis-regulatory
modules (CRMs) (1) responsible for transcription regulation.
CRMs are autonomous units of transcription programs encoded
in DNA (2–4) and are largely composed of transcription factor-
binding sites (TFBSs). Identification and categorization of the
entire repertoire of TFBSs are among the greatest challenges in
systems biology (5–7). Although CRM identification in lower
eukaryotes, such as various yeast species, has been progressing
rapidly (8, 9), similar efforts in vertebrates have proven to be
especially difficult due to the genomic and regulatory complexity
of the higher organisms (10). CRMs in vertebrate regulatory
regions not only control transcription during the life of individual
cells but also must orchestrate cellular communication during
tissue differentiation, morphogenesis, and body-part formation
(11), as well as maintain specific patterns of transcription in
terminally differentiated tissues (12).
Recent work to predict expression using cis-regulatory ele-
ments includes studies on yeast (6, 9, 13, 14), identification of
target genes and binding sites for specific transcription factors
(15, 16), and an evaluation of the effect of TFBS quality (17) on
target regulation. Bussemaker et al. (13) and Conlon et al. (14)
used linear regression to fit the count of predicted cis-regulatory
elements (13) or the sum of the likelihood ratios of all potential
cis-regulatory elements (14) to expression intensity. Beer and
Tavazoie (6) used cis-regulatory elements in promoters to
successfully predict gene expression patterns in yeast. Das et al.
(9) showed that CRMs in yeast promoters can be used to predict
gene expression during the cell cycle; they demonstrated that
nonlinear synergistic TFBS models significantly improve fit with
expression. Smith et al. (16) showed that CRMs composed of
synergistic TFBS pairs in human promoters predict chromatin
localization intensity of certain hepatocyte nuclear factors in
human liver and pancreatic islets. Papatsenko and Levine (17)
experimented with several enhancer evaluation methods, iden-
tifying the score of the highest-scoring site and the average score
across high-scoring sites as the best predictors for Dorsal binding
in the Drosophila embryo.
Here we show that CRMs in proximal promoters can be used
to predict differential expression of downstream target tran-
scripts in terminally differentiated tissues from human and
mouse. For each tissue, we identify a single CRM-based predic-
tor that distinguishes elevated from inhibited tissue-specific
expression. We analyze predictors for a selected set of human
tissues. These include predictors based on experimentally vali-
dated cis-regulatory elements and predictors that are composed
of cis-regulatory elements identified in silico and provide direc-
tion for targeted experiments to follow.
Results
We constructed predictors for 28 tissues with data in both human
and mouse. We show that 80% of these predictors distinguish
elevated from inhibited tissue-specific expression with statistical
significance. Full descriptions of predictors, including CRM
composition and interaction models, for each of the 56 tissues
are available from the authors. Here, we describe the most
significant components of the CD4 and CD8 T cell predictors
and demonstrate a relationship between correct prediction in
these tissues and location of highest-likelihood ETS-1 binding
sites. We highlight properties of the liver predictors, which are
composed of CRMs that were identified in silico. We discuss
similarities between predictors for trigeminal ganglion, dorsal
root ganglia, skeletal muscle, ovary, and salivary gland; predic-
tors for these tissues suggest large-scale cell-cycle arrest pheno-
type, and the inhibited genes with common predictor signatures
in these tissues are likely to be regulated by similar transcription-
factor complexes. We conclude with a study of the predictive
ability of tissue-specific predictors on other human tissues,
arguing that functional similarity exists between tissues with
common prediction patterns.
Tissue-Specific Expression Predictors. Each expression predictor
describes combinatorial and synergistic relations between exper-
imentally verified or in silico-identified cis-regulatory motifs and
CRMs; cis-regulatory motifs are modeled by using position
weight matrices (18, 19), and CRMs are sets of motifs hypoth-
esized to act synergistically. Prediction errors, their statistical
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significance, and corresponding classification errors are given in
Table 1 for each of the 28 human tissues. Results for mouse
tissues are given in Table 2, which is published as supporting
information on the PNAS web site. Our results indicate that
information in proximal promoters can predict differential ex-
pression of downstream target transcripts in terminally differ-
entiated tissues from human and mouse with statistically signif-
icant accuracy.
Detailed Treatment of Predictors. Predictors that include known
tissue-specific DNA motifs and previously observed synergy
include ETS, YY1, and CREB-binding motifs in human and
mouse T cells and lymph node; serum response factor and basic
helix–loop–helix-domain motifs in human heart; myocyte en-
hancer factor 2 (MEF-2)- and hepatocyte nuclear factor 4
(HNF)-4-binding motifs in mouse heart; myogenin, ETS- and
FoxJ-binding motifs in mouse heart; and HNF-4- and activating
protein 2 (AP-2)-binding motifs in mouse kidney. Human liver,
human testis, and mouse testis are the only tissues in which
predictors using a combination of novel and experimentally
verified motifs significantly outperformed predictors based only
on experimentally verified motifs. Our emphasis on large-scale
expression prediction implies that tissue-specific transcription
regulators that act on a relatively small set of target promoters
may not be included in final predictors. Motifs and modules
(constructed from both known and novel motifs) that best
predict elevated or inhibited tissue-specific expression on their
own are available from the authors. Tables 3 and 4, which are
published as supporting information on the PNAS web site,
include top experimentally verified binding-site motifs for hu-
man CD4 T cells and liver. Tables 5 and 6, which are published
as supporting information on the PNAS web site, include
modules constructed from experimentally verified binding-site
motifs for the same two tissues. An analysis of the testis predictor
is given in Fig. 4, which is published as supporting information
on the PNAS web site. Experimentally verified binding site
motifs that are not included in predictors but are good predictors
of elevated tissue-specific expression on their own include
MEF-2 and AP-2 motifs in mouse skeletal muscle, HNF-1 and
-4 motifs in mouse kidney, and an HNF-4 motif in human liver.
Finally, to measure tissue specificity of predictors, we apply each
statistically significant human predictor to other human tissues,
showing that most human predictors are specific to a single
related tissue or a small set of related tissues. The resulting
prediction errors are highly correlated (P  1.0E-16) with
common expression patterns calculated using the Eisen similar-
ity score (20). A full description of the human CD8 T cell
predictor is given in Table 7 and Fig. 5, which are published as
supporting information on the PNAS web site.
T Cells. Positive (and negative) sets for CD4 and CD8 human T
cells have large intersections (see Table 5), and their predictors
include common modules. Motifs associated with factors from
the ETS family play a central role in CD4 and CD8 T cell
expression prediction in both human and mouse. Fig. 1 shows
that the distribution of highest-likelihood ETS-binding sites in
correctly predicted positive-set promoters (true positives) is in
agreement with the distribution of experimentally verified ETS-
binding sites in human and mouse promoters, even though
position preference is not a feature used by the predictor. Scores
of highest-likelihood ETS-binding sites for false-positive predic-
tions are comparable to scores in true-positive promoters but are
less likely to occur near the transcription start site. Binding sites
for ETS-1 in human and ELK-1 in mouse are the best individual
expression predictors (see Table 3). CD4 and CD8 human T cell
predictors rely on synergistic relations between experimentally
verified DNA-binding motifs for ETS, YY1, and factors from the
CREB family. ETS-family factors are ubiquitously expressed
(21) but are well known to have an important role in regulation
of transcription in T cells (22, 23). Members of the ETS and
CREB families are known to interact (24–26). YY1 is a zinc-
finger regulator that acts as an activator or repressor in different
Table 1. Prediction accuracy for 28 human tissues
Tissue Terms ClassErr PredctErr P value
Skeletal muscle 7 0.313 0.343 2.9E-23
Liver 4 0.281 0.344 5.5E-23
Dorsal root ganglia 4 0.340 0.347 3.9E-22
Salivary gland 3 0.321 0.351 4.8E-21
Trigeminal ganglion 2 0.344 0.357 1.9E-19
Lung 3 0.329 0.359 6.2E-19
Ovary 3 0.372 0.385 6.5E-13
Testis 3 0.357 0.397 1.5E-10
Olfactory bulb 5 0.365 0.400 5.4E-10
Heart 5 0.346 0.402 1.2E-09
Kidney 5 0.360 0.402 1.2E-09
CD8 T cells 3 0.381 0.404 2.8E-09
Placenta 6 0.359 0.408 1.3E-08
CD4 T cells 6 0.370 0.415 1.8E-07
Prostate 7 0.378 0.425 5.2E-06
Cerebellum 6 0.352 0.430 2.4E-05
Adrenal gland 5 0.408 0.431 3.2E-05
Amygdala 6 0.365 0.436 1.3E-04
Thymus 4 0.379 0.436 1.3E-04
Pituitary 2 0.418 0.444 1.0E-03
Thyroid 3 0.420 0.445 1.7E-03
Pancreas 3 0.371 0.448 2.7E-03
Lymph node 3 0.392 0.453 9.8E-03
Bone marrow 2 0.402 0.456 1.5E-02
Uterus 2 0.423 0.456 1.5E-02
Trachea 4 0.393 0.467 1.2E-01
Adipose tissue 4 0.399 0.472 2.1E-01
Hypothalamus 3 0.398 0.487 1.0E00
For each human tissue, we present the number of MARS terms selected for
building the predictor to minimize prediction error (PredctErr), the classifica-
tion error (ClassErr) using this number of MARS terms, the prediction error
according to 10-fold crossvalidation, and the corresponding Bonferroni cor-
rected P value (corrected for MARS term selection). After correction, predic-
tors for bone marrow, uterus, trachea, adipose tissue, and hypothalamus fail
to predict significantly (P  0.01).
Fig. 1. Distributions of highest-likelihood ETS-binding site positions (rel-
ative to the TSS) in true-positive promoters in CD4 (a) and CD8 (b) T cells
agree with the distribution of relative positions of experimentally verified
ETS-binding sites. The distribution of 29 experimentally verified human
and mouse ETS-binding sites is given in red; 6 of the 29 occur outside of the
[1,000, 100] region and are counted but not presented. The distributions
of highest-likelihood ETS-binding site positions in the 299 and 325 correctly
predicted positive-set promoters (true positives) are given in blue, and the
distributions of the 169 and 206 incorrectly predicted negative-set pro-
moters (false positives) are given in green. Each graph point gives the
proportion of (verified or putative) binding sites in a window of length 100
that is centered at that point. False-positive predictions may include true
ETS-binding sites and show enrichment of sites near the transcription start
site, but this enrichment is considerably less pronounced.
6276  www.pnas.orgcgidoi10.1073pnas.0508169103 Smith et al.
contexts (27–29), and it has been observed to repress transcrip-
tion of genes outside of T cells and enhance their transcription
in T cells (30).
Liver.We predict differential expression in human liver with an
error rate of 0.344 (P  5.5E-23). Binding motifs for HNF-4
and -1 are among the best experimentally verified motifs at
predicting elevated expression in human and mouse liver; these
factors have been repeatedly shown to regulate transcription in
liver (15, 31). However, our predictor does not include binding
motifs for these factors and instead is composed of computa-
tionally predicted motifs that provide significantly better
prediction of differential expression. The liver predictor in-
cludes three modules. One is overrepresented in the positive
set, and the remaining two are overrepresented in the negative
set. The positive module has the greatest contribution to
prediction; it includes three compensatory CG-rich motifs
(modeled as additive) and is described in Fig. 2. Motifs 1 and
2 include a pair of CAGCTG patterns with different spacing,
and motif 3 includes one CAGCTG pattern. The CAGCTG
pattern is an excellent expression predictor in its own right,
with classification error rate of 0.323 compared with the
predictor’s 0.281.
Tissues with Cell-Cycle-Related Inhibition. Predictors of differential
expression in human trigeminal ganglion, skeletal muscle, ovary,
and salivary gland have a prediction error 0.36 and include
binding-site motifs for cell-cycle-related factors E2F¶, NRF-1,
and ETF. These binding motifs are found in combination with
motifs for members of the CREB family and NF-E1 in trigem-
inal ganglion, YY1 in ovary, and CEBP in salivary gland. The
human dorsal root ganglia predictor has a prediction error
0.35, and it includes a CG-rich binding motif for E2F and
binding motifs for ETF, CREB, and YY1. Negative promoter
sets in the five tissues have an unusually large intersection (see
Table 8, which is published as supporting information on the
PNAS web site), and Fig. 3 shows that predictors for any one of
these tissues do well on the other tissues even when this
intersection is excluded. In addition, cell-cycle activation and
inhibition through interactions among E2F-1 and CREB,
NRF-1, YY1, DP, or ETF have been previously described (32,
33). These cell-cycle-related motifs are enriched in the negative
sets, suggesting that the five tissues have unusually strong
cell-cycle-related inhibition. This finding is consistent with phys-
iological properties shared by the five tissues. Adult trigeminal
ganglion, dorsal root ganglia, and skeletal muscle are in cell-
cycle arrest, which is mediated by E2F factors in synergistic
activity with Rb, Myc, and cyclin factors (34–36). In Drosophila,
which is often used as a model organism for studying the
mammalian cell cycle, endocycle (37), ovary, and salivary gland
cells as they enter the endocycle and become polyploid. In this
state, many E2F-regulated and mitosis-associated transcripts are
inhibited (38). Genes correctly predicted in ovary and salivary
gland negative sets include nuclear mitotic apparatus protein 1
(NUMA1), HLA-B associated transcript 3 (BAT3), kelch do-
main containing 3 (KLHDC3), and DEAH box polypeptide 30
(DHX30). Genes correctly predicted in negative sets common to
the five tissues are implicated in protein transport andmembrane
trafficking and include adaptor-related protein complex 3
(AP3D1), pleckstrin homology Sec7 coiled-coil domains 2
(PSCD2), and arsA arsenite transporter ATP-binding homolog
1 (ASNA1). Complete sets of transcripts from positive and
negative sets are available from the authors, along with the
predicted class of each transcript.
Tissue-Specific Predictor Evaluation on Other Tissues.We wanted to
determine whether the predictors trained on one tissue could
provide statistically significant predictions in other tissues. Fig.
3 summarizes the prediction quality of each human predictor on
each human tissue, excluding tissues and corresponding predic-
tors that fail the statistical significance test. Fig. 6, which is
published as supporting information on the PNAS web site, has
the analogous data for mouse. We are interested in prediction
quality and not classification quality and do not consider pro-
moters that were included in the training set: a promoter that is
common to tissues T1 and T2 is not included when using the
predictor trained on T1 to predict expression in T2. Tables 8 and
9, which are published as supporting information on the PNAS
web site, describe the common promoter composition in the
positive and negative sets of each tissue pair. Tissues with
common predictor patterns tend to be functionally related.
Predictors include common patterns in amygdala, cerebellum,
and, to a lesser extent, olfactory bulb; CD4 and CD8 T cells;
internal organs; and tissues in cell-cycle arrest. Lung, and to a
lesser degree heart, can be predicted with statistical significance
using CG content; predictors that reward high CG content in
the positive set and high AT content in the negative set are
more likely to predict these tissues with significance.
Discussion
We demonstrate that CRMs in human and mouse proximal
promoters contain sufficient information to predict with statis-
tically significant accuracy whether target genes have elevated or
inhibited expression in many terminally differentiated tissues.
Our work proves that CRM-based in silico expression prediction
is possible for mammals even without the use of distal regions.
The majority of our predictors are statistically significant, but
our best predictors have a prediction error of 35%, which is high
relative to previously observed expression prediction errors in
yeast (6). Sequence-based prediction of expression in mammals
will significantly improve as cell-based (instead of tissue-based)
data become available, with transcript- instead of gene-centric
expression microarrays, with improved transcription start site
(TSS) annotation that includes alternative TSS data, with better
characterization of general and specific TFBSs, and with com-
putational methods that account for chromatin remodeling and
distal CRMs further upstream and in intronic regions (39, 40).
We present a detailed in silico study of predictors for human
CD4 and CD8 T cells and a predictor for human liver that is
composed of novel motifs. We show that promoters of tissue-
specific inhibited transcripts in human trigeminal ganglion,
dorsal root ganglia, skeletal muscle, ovary, and salivary gland
¶The negative set in the ovary is enriched for an experimentally verified E2F-1-binding
motif, and negative sets in skeletal muscle, salivary gland, and trigeminal ganglion are
enriched for an experimentally verified E2F-1-, -3-, and -4-binding motif.
Fig. 2. Transcripts for which the sum of the scores of the best matches for the
three novel motifs is 13.5 are predicted to have elevated expression in
human liver. (a) The three motifs are enriched with CAGCTG (emphasized),
and CAGCTG frequency is a significant predictor of differential expression
with classification error of 0.323 compared with classification error of 0.281 of
the liver predictor. (b) CAGCTG frequency in promoters of transcripts with
inhibited (0.0217 pointed in green) and elevated (0.0260 pointed in red)
expression in human liver are compared with CAGCTG frequency distribution
in 10,000 randomly selected human promoter sets (of the same size) from
CSHLmpd. CAGCTG frequency in the randomly selected human promoter sets
is Gaussian with (, )  (0.0235, 0.00024).
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include binding-site patterns for cell-cycle regulators; these
terminally differentiated tissues are known to be in cell-cycle
arrest. Predictors trained to recognize tissue-specific expression
in one tissue recognize tissue-specific expression in that tissue
and a few related tissues with common function or lineage.
Promoter sets corresponding to transcripts with tissue-specific
enhanced and inhibited expression together with calls by tissue-
specific predictors are available from the authors. We also
provide known and computationally predicted motifs and mod-
ules that best predict tissue-specific enhanced and inhibited
expression. Predictors, motifs, modules, and transcript sets
present opportunity for further study, including identification of
cooperative core, proximal and distal elements, verification of
predicted synergistic relations and computationally predicted
motifs, and construction of better-informed gene networks.
Tools developed in this work are freely available and can be
reapplied to study transcription regulation of other differentially
expressed gene sets.
We use proximal promoter elements to predict expression
and do not consider contribution from distal regulatory ele-
ments. Distal regulatory elements are rare in yeast but are
likely to be major contributors to the diversity seen in higher
eukaryotes (3, 41) and are important for understanding the
dynamics of metazoan gene regulation. They are known to
regulate chromatin modification and often include motifs that
are also present in the proximal or core promoter (10). We
identify a significant role for proximal promoter elements in
determining tissue specificity. Our results complement, rather
than conf lict with, theories that describe distal mediation of
cell type- or tissue-specific regulation. Observed synergistic
activity between distal, proximal, and core elements (3, 10, 42)
and proximal element competition for distal CRMs (43, 44)
suggests that recruitment of distal CRMs may be the respon-
sibility of elements located near transcription start sites. In this
paper, we focus on demonstrating that tissue-specific patterns
of expression could be predicted by proximal promoter motifs
and give only a limited description of the predictive models in
a few tissues. To accurately evaluate and compare prediction
errors, we use large and equal-size transcript sets. One of the
drawbacks of such inquiry is that tissue-specific cis-regulatory
motifs and CRMs with relatively few target genes do not
appear significant, even when they play a central role in
tissue-specific functions. An investigation of transcripts with
higher tissue specificity reveals overrepresentation of binding
sites for factors that are known to regulate tissue-specific
expression but are not included among our top motif and
module predictors. A comprehensive study that aims to better
catalog all tissue-specific cis-regulatory motifs and modules in
human and mouse proximal promoters will be published
separately.
Fig. 3. Prediction error of CRM-based predictors (on the right) trained on specific tissues and tested on all tissues (at the top). Errors below, at, and above 45%
are displayed in red, black, and green, respectively. The diagonal, corresponding to predictors trained and tested on the same tissue, gives prediction error
10-fold crossvalidation. When applying a predictor to a tissue other than that on which it was trained, promoters common to both tissues are excluded. Tissues
and corresponding predictors with crossvalidation error P value above the 0.01 significance cutoff are omitted. Tissue order corresponds to physiological
properties: brain tissues, T cells, endocrine glands, internal organs, and tissues in cell-cycle arrest. Complete predictors for all tissues, promoter sets, and predictor
calls for each promoter are available from the authors.
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Materials and Methods
We focus on large-scale tissue-specific differential expression
and identify patterns of regulation that are common to promot-
ers of hundreds of transcripts with tissue-specific behavior. For
each tissue, we construct a positive and negative promoter set,
each of size 500. This size is a compromise between tissue
specificity and statistical power. These uniform-size sets include
promoters of transcripts that are not tissue-specific in some
tissues and exclude promoters of transcripts that are tissue-
specific in other tissues. Benefits of using large and uniform-size
sets include consistent prediction estimates that are comparable
across tissues and robustness to outliers and features that are
shared by few promoters. Drawbacks include higher estimates of
prediction error and increased noise. The positive set for each
tissue includes Cold Spring Harbor Laboratory Mammalian
Promoter Database (CSHLmpd) (45) promoters of transcripts
with the most elevated expression, measured in terms of stan-
dard deviations from their mean intensity over all tissues studied
by Su et al. (46). The negative set includes CSHLmpd promoters
of transcripts with inhibited expression under the same criteria.
Each promoter sequence is taken 1,000 bp upstream to 100 bp
downstream from the CSHLmpd-annotated transcription start site.
Predictors are constructed sequentially, identifying potential
master-regulator binding-site motifs (47) and potential syner-
gistic motifs, combining them into small CRMs, and modeling
CRM interactions to predict elevated or inhibited expression.
Master-regulator binding motifs and potential synergistic motifs
are selected from experimentally verified motifs in the TRANS-
FAC (48) database (called known motifs) and supplemented
with motifs identified in silico using DME (49) (called novel
motifs). Motifs are combined into pairs and triples to form
putative CRMs based on their combined ability to differentiate
positive from negative promoters. Predictors are constructed from
CRMs using multivariate adaptive regression splines (MARS) (9,
16, 50). MARS can predict the linear and nonlinear relation
between CRMs, capturing a multitude of interactive behaviors.
We outline our methods below. Motif identification software
is available by request from the authors. Motif analysis, CRM
construction, and CRM evaluation programs are a part of the
open source package CREAD, which is available from the authors.
Data Preparation. The microarray expression experiments of Su et
al. (46) include 28 tissues with experiments on human and mouse
(see Table 1). We concentrate on these tissues and assign probes
to transcripts through mapping probe location back to National
Center for Biotechnology Information human genome assembly
Hs33 and mouse genome assembly v3C (dating to February
2003). Each transcript was assigned mean intensity over exper-
iments and probes and mapped to a transcription start site in
CSHLmpd (45), when possible. Transcripts with no transcription
start site annotation in CSHLmpd were discarded. Each tran-
script with known transcription start site was assigned a proximal
promoter consisting of the DNA sequence from 1,000 to 100
relative to its transcription start site. Positive and negative
promoter sets for each tissue, each of size 500, were assembled
by using unique promoters of transcripts with the most elevated
and inhibited (respectively) tissue-specific expression, measured
in terms of the number of standard deviations from the tran-
script’s mean intensity over all tissues. Summary information for
probe presentabsent calls, mapping to transcripts, and tissue
data are given in Tables 10, 11, and 12, which are published as
supporting information on the PNAS web site.
Motifs and Motif Modules. Motifs are represented by using the
position weight matrix model (18, 19), and putative motif
occurrences are scored by using a log-likelihood function (51).
Two distinct motifs are compared by using MATCOMPARE (52)
and the information divergence measure. Motifs are taken from
the vertebrate subset of TRANSFAC 8.3 (48) and identified de
novo by using the original DME algorithm (49) and a modified
version that considers only the best occurrences in each se-
quence. Given positive (Pos) and negative (Neg) sequence sets
and the base composition f of Pos  Neg, DME iteratively
identifies the top motif M, ranked according to the ratio
LPos,P(M, f )LNeg,Q(M, f ) of maximum likelihood scores, where
LS,Z(M, f ) is the likelihood of M and base composition f, given
sequence set S with values for the missing data Z maximizing the
equation:
LF,ZM, f  
siF
Pr(s iM) ziPr(s if) 1zi. [1]
The modified version of DME identifies motifs to maximize the
difference between the number of sequences in Pos and Neg that
contain sites that are more likely to be generated from M than
from f, with ties broken in favor of sensitivity. Both algorithms
consider sites on the forward and reverse complement strands.
For each tissue, 150 motifs (widths 8, 10, and 12) were identified
by using the two programs.
Motifs were evaluated, ranked, pruned, and grouped into
modules using the CREAD programs MOTIFCLASS, SORTMOTIFS,
UNIQMOTIFS, and MODCLASS. Motif quality was measured by
using classification error rate based on the maximum scoring
sequence in a given promoter and its reverse compliment and a
threshold set to minimize this error using MOTIFCLASS. Motifs
found to be similar to higher-quality motifs were eliminated by
using UNIQMOTIFS. Motif modules (sets of motifs) were con-
structed by identifying motif sets with low classification error
using independently set thresholds by MODCLASS. We con-
structed modules of size 2 by exhaustive evaluation of motif pairs
and modules of size 3 from which each pair of single motifs was
a high-ranking size 2 module. More details on these programs
can be found in Supporting Text, which is published as supporting
information on the PNAS web site.
Predictor Construction.Predictors are constructed with theMARS
algorithm (9, 16, 50) by using motif and module features. We
used MARS to construct predictors that include seven terms
using stepwise forward addition of linear splines and their
products. We then used backward elimination to reduce the size
of predictors to two terms. Splines operate on basis functions of
the form {1, max(siki, 0), max(i  sik, 0)}, where sik is the
value of feature i on sequence k. Splines can be combined using
addition or multiplication to model linear and nonlinear rela-
tionships. Supporting Text contains a full list of the features we
tested. We provided MARS with a restricted set of features,
including the max-score feature for motifs and the max-score-
sum and max-score-product features for modules. For a given
motif, the max-score feature assigns to each promoter the score
of the highest matching substring in the promoter and its reverse
complement. The max-score-sum and max-score-product fea-
tures assign to each promoter the sum of max-scores and product
of max-scores over all motifs in the module, respectively. Pre-
liminary experiments indicated that the best models were most
often built by using features of those types, and a general
restriction in the complexity of the feature space is required to
prevent overfitting.
MARS builds predictive models (in our case CRMs) by
iteratively adding terms and factors to a spline-based polynomial.
It makes greedy local moves, adding the best possible term at
each forward step and removing the least effective term at each
backward step. MARS may fail to identify the best combination
of terms if these terms are not individually dominant. Although
MARS is designed to perform regression, it will function as a
classifier when given 11 response variables as input. Positive
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and negative responses correspond to positive and negative
prediction. Supporting Text contains additional details on the
MARS algorithm. Most predictors were constructed by using
experimentally verified motifs and modules composed of exper-
imentally verified motifs. Novel motifs were used only when they
provided a significantly improved prediction.
Evaluating Predictive Ability. We used 10-fold crossvalidation to
estimate prediction error. The procedure is as follows: (i) the
data are randomly partitioned into 10 subsets; (ii) each subset is
removed exactly once from the data, and a predictor is trained
on the remaining 90% and tested on the removed subset; and (iii)
the classification errors are summed over each subset, producing
the prediction error. We assume that an uninformed random
predictor will make a correct prediction with probability 0.5. We
stress that motif identification and optimization must be done
only after removal of the testing subset. Approaches that identify
and optimize motifs on the entire set, build predictors on a
subset, and test on another subset grossly underestimate predic-
tion errors. Our predictors contain no information about the test
set, and their predictive error can be directly used to evaluate
their quality. We used MARS to build predictors up to seven
terms and iteratively removed the weakest term from each
predictor until reaching a predictor of size 2, resulting in six
predictors. The best model size with minimum prediction error
was selected, and MARS was then applied to build a predictor
of that size using the entire data set.
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